 |
 |
ROCKVILLE, Md., Feb. 18, 2010--The FDA has posted on its website a letter regarding two television ads for the Alzheimer’s disease drug Aricept. The agency said the ads are misleading because they overstate the drug's efficiacy.
Posted: February 2010
FDA is alerting health care providers of concerns about a lack of sterility assurance of all sterile drug products made and distributed by NuVision...
Pentec Health, Inc. initiated a limited, voluntary recall of in-date nutritional prescriptions for renal patients due to lack of sterility assurance...
Including Ambien, Ambien CR, Edluar, and Zolpimist [UPDATE 05/14/2013] Today, the U.S. Food and Drug Administration (FDA) is notifying the public...
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Apr 24th, 2013), Cerner Multum™ (updated Apr 19th, 2013), Wolters Kluwer™ (updated Apr 30th, 2013) and others. To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2013 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
